iOncologi, Inc. Expands Immunotherapy Capabilities with TargImmune Acquisition iOncologi, Inc. announces the acquisition of TargImmune Therapeutics to enhance its immunotherapy pipeline aimed at solid tumors. This strategic move reinforces its mission in cancer treatment.

iOncologi, Inc. Expands Immunotherapy Capabilities with TargImmune Acquisition #United_States #Gainesville #Immunotherapy #iOncologi #TargImmune